Why not?
By then they should have 2 drugs in market with U$3B revenue at 90% margins and another $10B one close...plus any others added in the interim. $12B at 90% = $10.8B net revenue - less overheads (relatively minor) and at say 10x PE would give the co a market cap of circa $108B.
OK, so all may not make it, revenue might not be as much as advertised, risks need to be factored in etc....but no doubt the potential is there and $35B is around 1/3 of that potential.
So, again, why not?
- Forums
- ASX - By Stock
- PYC
- PYC Filed Another Patent
PYC Filed Another Patent, page-32
Featured News
Add PYC (ASX) to my watchlist
(20min delay)
|
|||||
Last
13.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $606.5M |
Open | High | Low | Value | Volume |
13.5¢ | 13.5¢ | 12.5¢ | $17.86K | 137.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
11 | 1081168 | 12.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
13.0¢ | 505604 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
10 | 1069168 | 0.125 |
11 | 1346557 | 0.120 |
12 | 1239403 | 0.115 |
10 | 403370 | 0.110 |
13 | 1221009 | 0.105 |
Price($) | Vol. | No. |
---|---|---|
0.135 | 537674 | 5 |
0.140 | 1117191 | 5 |
0.145 | 256800 | 2 |
0.150 | 525000 | 3 |
0.165 | 23000 | 1 |
Last trade - 16.10pm 05/07/2024 (20 minute delay) ? |
Featured News
PYC (ASX) Chart |